The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Platinum or non-platinum therapy in post-olaparib recurrent ovarian cancer: Analysis in matched cohorts.
 
Alexey Rumyantsev
Honoraria - AstraZeneca; BIOCAD; Merck; Pfizer
Consulting or Advisory Role - AstraZeneca; Merck; Pfizer
Speakers' Bureau - AstraZeneca; Merck
Travel, Accommodations, Expenses - AstraZeneca; Merck
 
Ilya Pokataev
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Eisai; Merck; Novartis; Pfizer; Pierre Fabre; Roche; Swixx BioPharma
 
Elena Glazkova
Honoraria - AstraZeneca; Novartis; Pfizer
Travel, Accommodations, Expenses - R-Pharm
 
Anna Lud
No Relationships to Disclose
 
Mikhail Fedyanin
No Relationships to Disclose
 
Sergei Tjulandin
Stock and Other Ownership Interests - RosPharmTech
Consulting or Advisory Role - AstraZeneca; SERVIER
Speakers' Bureau - AstraZeneca
Research Funding - Abbvie (Inst); Eisai (Inst); Merck (Inst); Novartis (Inst); SERVIER